LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 140

Search options

  1. Article ; Online: Urine lactate concentration as a non-invasive screener for metabolic abnormalities: Findings in children with autism spectrum disorder and regression.

    Boterberg, Sofie / Vantroys, Elise / De Paepe, Boel / Van Coster, Rudy / Roeyers, Herbert

    PloS one

    2022  Volume 17, Issue 9, Page(s) e0274310

    Abstract: There is increasing evidence that diseases caused by dysfunctional mitochondria (MD) are associated with autism spectrum disorder (ASD). A comprehensive meta-analysis showed that developmental regression was reported in half of the children with ASD and ... ...

    Abstract There is increasing evidence that diseases caused by dysfunctional mitochondria (MD) are associated with autism spectrum disorder (ASD). A comprehensive meta-analysis showed that developmental regression was reported in half of the children with ASD and mitochondrial dysfunction which is much higher than in the general population of ASD. The aim of the present exploratory study was to determine lactate concentrations in urine of children with ASD, as a non-invasive large-scale screening method for metabolic abnormalities including mitochondrial dysfunction and its possible association with regression. First, clinical characteristics of MD were examined in 99 children (3-11 years) with ASD. Second, clinical characteristics of MD, severity of ASD and reported regression were compared between children with the 20% lowest lactate concentrations and those with the 20% highest lactate concentrations in urine. Third, clinical characteristics of MD and lactate concentration in urine were compared in children with (n = 37) and without (n = 62) reported regression. An association of urine lactate concentrations with mitochondrial dysfunction and regression could not be demonstrated in our large ASD cohort. However, since ASD children were reported by their parents to show a broad range of phenotypic characteristics of MD (e.g., gastro-intestinal and respiratory impairments), and lactate concentrations in urine are not always increased in individuals with MD, the presence of milder mitochondrial dysfunction cannot be excluded. Development of alternative biomarkers and their implementation in prospective studies following developmental trajectories of infants at elevated likelihood for ASD will be needed in the future to further unravel the association of ASD with mitochondrial dysfunction and eventually improve early detection.
    MeSH term(s) Autism Spectrum Disorder/metabolism ; Biomarkers/metabolism ; Child ; Humans ; Lactic Acid/metabolism ; Mitochondria/metabolism ; Prospective Studies
    Chemical Substances Biomarkers ; Lactic Acid (33X04XA5AT)
    Language English
    Publishing date 2022-09-09
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0274310
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Neonatal lactic acidosis explained by LARS2 defect.

    De Paepe, Boel / Smet, Joél / Kopajtich, Robert / Prokisch, Holger / Van Coster, Rudy / Vanlander, Arnaud

    Pediatric research

    2022  Volume 93, Issue 4, Page(s) 740–743

    MeSH term(s) Infant, Newborn ; Humans ; Acidosis, Lactic ; Acidosis ; Amino Acyl-tRNA Synthetases
    Chemical Substances LARS2 protein, human (EC 6.1.1.4) ; Amino Acyl-tRNA Synthetases (EC 6.1.1.-)
    Language English
    Publishing date 2022-06-24
    Publishing country United States
    Document type Letter
    ZDB-ID 4411-8
    ISSN 1530-0447 ; 0031-3998
    ISSN (online) 1530-0447
    ISSN 0031-3998
    DOI 10.1038/s41390-022-02169-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Characteristics, Early Development and Outcome of Parent-Reported Regression in Autism Spectrum Disorder.

    Boterberg, Sofie / Van Coster, Rudy / Roeyers, Herbert

    Journal of autism and developmental disorders

    2019  Volume 49, Issue 11, Page(s) 4603–4625

    Abstract: This study explored regression patterns in 100 children with ASD (3-11 years) using several approaches to enhance the validity of retrospective parent report. Both early development and outcome were examined in regression groups defined by 36 months age ... ...

    Abstract This study explored regression patterns in 100 children with ASD (3-11 years) using several approaches to enhance the validity of retrospective parent report. Both early development and outcome were examined in regression groups defined by 36 months age cut-off and two underlying empirical patterns based on type and onset age. Results over regression groups were generally consistent. During early development, children with regression showed a similar amount of social atypicalities and stereotyped behaviour as compared to children without regression. However, parents indicated less communication skills which could be a valuable predictor of regression. Development after regression was characterised by early language delay and more restricted and repetitive behaviour. The findings provide insight into the diagnosis and prognosis of regression in ASD.
    MeSH term(s) Age of Onset ; Autism Spectrum Disorder/diagnosis ; Autism Spectrum Disorder/psychology ; Autism Spectrum Disorder/therapy ; Child ; Child Development/physiology ; Child, Preschool ; Female ; Humans ; Language Development Disorders/diagnosis ; Language Development Disorders/psychology ; Language Development Disorders/therapy ; Male ; Parents/psychology ; Regression, Psychology ; Retrospective Studies ; Stereotyped Behavior/physiology ; Treatment Outcome
    Language English
    Publishing date 2019-08-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 391999-7
    ISSN 1573-3432 ; 0162-3257
    ISSN (online) 1573-3432
    ISSN 0162-3257
    DOI 10.1007/s10803-019-04183-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders

    De Paepe, Boel / Van Coster, Rudy

    Nutrients. 2017 Sept. 14, v. 9, no. 9

    2017  

    Abstract: In human cells, mitochondria provide the largest part of cellular energy in the form of adenosine triphosphate generated by the process of oxidative phosphorylation (OXPHOS). Impaired OXPHOS activity leads to a heterogeneous group of inherited diseases ... ...

    Abstract In human cells, mitochondria provide the largest part of cellular energy in the form of adenosine triphosphate generated by the process of oxidative phosphorylation (OXPHOS). Impaired OXPHOS activity leads to a heterogeneous group of inherited diseases for which therapeutic options today remain very limited. Potential innovative strategies aim to ameliorate mitochondrial function by increasing the total mitochondrial load of tissues and/or to scavenge the excess of reactive oxygen species generated by OXPHOS malfunctioning. In this respect, resveratrol, a compound that conveniently combines mitogenetic with antioxidant activities and, as a bonus, possesses anti-apoptotic properties, has come forward as a promising nutraceutical. We review the scientific evidence gathered so far through experiments in both in vitro and in vivo systems, evaluating the therapeutic effect that resveratrol is expected to generate in mitochondrial patients. The obtained results are encouraging, but clearly show that achieving normalization of OXPHOS function with this strategy alone could prove to be an unattainable goal.
    Keywords adenosine triphosphate ; antioxidant activity ; dietary supplements ; energy ; genetic disorders ; humans ; mitochondria ; oxidative phosphorylation ; patients ; reactive oxygen species ; resveratrol ; therapeutics ; tissues
    Language English
    Dates of publication 2017-0914
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2518386-2
    ISSN 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu9091017
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders.

    De Paepe, Boel / Van Coster, Rudy

    Nutrients

    2017  Volume 9, Issue 9

    Abstract: In human cells, mitochondria provide the largest part of cellular energy in the form of adenosine triphosphate generated by the process of oxidative phosphorylation (OXPHOS). Impaired OXPHOS activity leads to a heterogeneous group of inherited diseases ... ...

    Abstract In human cells, mitochondria provide the largest part of cellular energy in the form of adenosine triphosphate generated by the process of oxidative phosphorylation (OXPHOS). Impaired OXPHOS activity leads to a heterogeneous group of inherited diseases for which therapeutic options today remain very limited. Potential innovative strategies aim to ameliorate mitochondrial function by increasing the total mitochondrial load of tissues and/or to scavenge the excess of reactive oxygen species generated by OXPHOS malfunctioning. In this respect, resveratrol, a compound that conveniently combines mitogenetic with antioxidant activities and, as a bonus, possesses anti-apoptotic properties, has come forward as a promising nutraceutical. We review the scientific evidence gathered so far through experiments in both in vitro and in vivo systems, evaluating the therapeutic effect that resveratrol is expected to generate in mitochondrial patients. The obtained results are encouraging, but clearly show that achieving normalization of OXPHOS function with this strategy alone could prove to be an unattainable goal.
    MeSH term(s) Adenosine Triphosphate/metabolism ; Apoptosis/drug effects ; Dietary Supplements ; Humans ; Mitochondria/drug effects ; Mitochondria/metabolism ; Mitochondrial Diseases/drug therapy ; Oxidative Phosphorylation/drug effects ; Reactive Oxygen Species/metabolism ; Resveratrol ; Stilbenes/pharmacology
    Chemical Substances Reactive Oxygen Species ; Stilbenes ; Adenosine Triphosphate (8L70Q75FXE) ; Resveratrol (Q369O8926L)
    Language English
    Publishing date 2017-09-14
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu9091017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: mTOR Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells.

    Dewaele, Shanna / Delhaye, Louis / De Paepe, Boel / Bogaert, Bram / Martinez, Ramiro / Anckaert, Jasper / Yigit, Nurten / Nuytens, Justine / Van Coster, Rudy / Eyckerman, Sven / Raemdonck, Koen / Mestdagh, Pieter

    Nucleic acid therapeutics

    2023  Volume 33, Issue 4, Page(s) 248–264

    Abstract: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Owing to a lack of effective treatments, patients with metastatic disease have a median survival time of 6-12 months. We recently demonstrated that the Survival Associated ... ...

    Abstract Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Owing to a lack of effective treatments, patients with metastatic disease have a median survival time of 6-12 months. We recently demonstrated that the Survival Associated Mitochondrial Melanoma Specific Oncogenic Non-coding RNA
    MeSH term(s) Humans ; Oligonucleotides, Antisense/genetics ; Oligonucleotides, Antisense/pharmacology ; Oligonucleotides, Antisense/therapeutic use ; Cell Line, Tumor ; Melanoma/drug therapy ; Melanoma/genetics ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism ; RNA, Small Interfering/therapeutic use
    Chemical Substances Oligonucleotides, Antisense ; TOR Serine-Threonine Kinases (EC 2.7.11.1) ; RNA, Small Interfering
    Language English
    Publishing date 2023-06-30
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2639888-6
    ISSN 2159-3345 ; 2159-3337
    ISSN (online) 2159-3345
    ISSN 2159-3337
    DOI 10.1089/nat.2023.0008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Case report: Thirty-year progression of an EMPF1 encephalopathy due to defective mitochondrial and peroxisomal fission caused by a novel

    Lhuissier, Charlène / Wagner, Bart E / Vincent, Amy / Garraux, Gaëtan / Hougrand, Olivier / Van Coster, Rudy / Benoit, Valerie / Karadurmus, Deniz / Lenaers, Guy / Gueguen, Naïg / Chevrollier, Arnaud / Maystadt, Isabelle

    Frontiers in neurology

    2022  Volume 13, Page(s) 937885

    Abstract: Mutations ... ...

    Abstract Mutations in
    Language English
    Publishing date 2022-09-23
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2564214-5
    ISSN 1664-2295
    ISSN 1664-2295
    DOI 10.3389/fneur.2022.937885
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Mild myopathic phenotype in a patient with homozygous c.416C > T mutation in

    Papadimas, George K / Vargiami, Efthimia / Dragoumi, Pinelopi / Van Coster, Rudy / Smet, Joel / Seneca, Sara / Papadopoulos, Constantinos / Kararizou, Evangelia / Zafeiriou, Dimitrios

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology

    2020  Volume 39, Issue 2, Page(s) 94–97

    Abstract: The mitochondrial DNA depletion syndrome (MDDS) is characterized by extensive phenotypic variability and is due to nuclear gene mutations resulting in reduced mtDNA copy number. Thymidine kinase 2 (TK2) mutations are well known to be associated with MDDS. ...

    Abstract The mitochondrial DNA depletion syndrome (MDDS) is characterized by extensive phenotypic variability and is due to nuclear gene mutations resulting in reduced mtDNA copy number. Thymidine kinase 2 (TK2) mutations are well known to be associated with MDDS. Few severely affected cases carrying the c.416C > T mutation in
    MeSH term(s) Child, Preschool ; Humans ; Infant ; Male ; Mitochondrial Diseases/complications ; Mitochondrial Diseases/genetics ; Mitochondrial Diseases/pathology ; Muscular Diseases/complications ; Muscular Diseases/genetics ; Muscular Diseases/pathology ; Mutation/genetics ; Thymidine Kinase/genetics
    Chemical Substances thymidine kinase 2 (EC 2.7.1.-) ; Thymidine Kinase (EC 2.7.1.21)
    Language English
    Publishing date 2020-06-01
    Publishing country Italy
    Document type Case Reports ; Journal Article
    ZDB-ID 2102328-1
    ISSN 2532-1900 ; 1128-2460
    ISSN (online) 2532-1900
    ISSN 1128-2460
    DOI 10.36185/2532-1900-012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Phenotypic spectrum of the RBM10-mediated intellectual disability and congenital malformation syndrome beyond classic TARP syndrome features.

    Kumps, Candy / D'haenens, Erika / Vergult, Sarah / Leus, Jasmine / van Coster, Rudy / Jansen, Anna / Devriendt, Koen / Oostra, Anna / Vanakker, Olivier M

    Clinical genetics

    2021  Volume 99, Issue 3, Page(s) 449–456

    Abstract: Pathogenic variants in the RBM10 gene cause a rare X-linked disorder described as TARP (Talipes equinovarus, Atrial septal defect, Robin sequence, and Persistent left vena cava superior) syndrome. We report two novel patients with truncating RBM10 ... ...

    Abstract Pathogenic variants in the RBM10 gene cause a rare X-linked disorder described as TARP (Talipes equinovarus, Atrial septal defect, Robin sequence, and Persistent left vena cava superior) syndrome. We report two novel patients with truncating RBM10 variants in view of the literature, presenting a total of 26 patients from 15 unrelated families. Our results illustrate the highly pleiotropic nature of RBM10 pathogenic variants, beyond the classic TARP syndrome features. Major clinical characteristics include severe developmental delay, failure to thrive, brain malformations, neurological symptoms, respiratory issues, and facial dysmorphism. Minor features are growth retardation, cardiac, gastrointestinal, limb, and skeletal abnormalities. Additional recurrent features include genital and renal abnormalities as well as hearing and visual impairment. Thus, RBM10 loss of function variants typically cause an intellectual disability and congenital malformation syndrome that requires assessment of multiple organ systems at diagnosis and for which provided clinical features might simplify diagnostic assessment. Furthermore, evidence for an RBM10-related genotype-phenotype correlation is emerging, which can be important for prognosis.
    MeSH term(s) Child ; Child, Preschool ; Clubfoot/genetics ; Genetic Association Studies ; Genetic Variation ; Heart Defects, Congenital/genetics ; Humans ; Intellectual Disability/diagnosis ; Intellectual Disability/genetics ; Loss of Function Mutation ; Male ; Nervous System Malformations/diagnosis ; Nervous System Malformations/genetics ; Phenotype ; Pierre Robin Syndrome/genetics ; Prognosis ; RNA-Binding Proteins/genetics
    Chemical Substances RBM10 protein, human ; RNA-Binding Proteins
    Language English
    Publishing date 2021-01-05
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 221209-2
    ISSN 1399-0004 ; 0009-9163
    ISSN (online) 1399-0004
    ISSN 0009-9163
    DOI 10.1111/cge.13901
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: RFC1 repeat expansions: A recurrent cause of sensory and autonomic neuropathy with cough and ataxia.

    Beijer, Danique / Dohrn, Maike F / De Winter, Jonathan / Fazal, Sarah / Cortese, Andrea / Stojkovic, Tanya / Fernández-Eulate, Gorka / Remiche, Gauthier / Gentile, Mattia / Van Coster, Rudy / Dufke, Claudia / Synofzik, Matthis / De Jonghe, Peter / Züchner, Stephan / Baets, Jonathan

    European journal of neurology

    2022  Volume 29, Issue 7, Page(s) 2156–2161

    Abstract: Background and purpose: Ataxia and cough are rare features in hereditary sensory and autonomic neuropathies (HSAN), a group of diseases of mostly unknown genetic cause. Biallelic repeat expansions in RFC1 are associated with cerebellar ataxia, ... ...

    Abstract Background and purpose: Ataxia and cough are rare features in hereditary sensory and autonomic neuropathies (HSAN), a group of diseases of mostly unknown genetic cause. Biallelic repeat expansions in RFC1 are associated with cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS). This study aimed to investigate the prevalence of RFC1 repeat expansions in a cohort of HSAN patients.
    Methods: After unremarkable whole-exome sequencing (WES) analysis, we performed repeat-primed PCR to detect intronic RFC1 expansions in 12 HSAN families, who all presented with chronic cough.
    Results: In these patients, 75% carried biallelic expansions of the pathogenic AAGGG motif. Compared with RFC1-/- cases, RFC1+/+ cases presented more consistently with positive sensory and autonomic symptoms. Afferent ataxia was more severe in the RFC1+/+ cohort and cerebellar ataxia was a common feature (21%).
    Conclusions: We demonstrate that RFC1 is a frequent cause of (WES-negative) HSAN with chronic cough and ataxia. The diagnostic yield of RFC1 repeat-primed PCR was surprisingly high, given that HSAN is genetically poorly understood. This combination of HSAN, ataxia, and chronic cough symptoms represents a new nosological entity within the neuropathy-ataxia spectrum.
    MeSH term(s) Ataxia ; Bilateral Vestibulopathy ; Cerebellar Ataxia/diagnosis ; Cerebellar Ataxia/genetics ; Cough/genetics ; Hereditary Sensory and Autonomic Neuropathies/genetics ; Humans ; Peripheral Nervous System Diseases/complications ; Vestibular Diseases
    Language English
    Publishing date 2022-03-23
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1280785-0
    ISSN 1468-1331 ; 1351-5101 ; 1471-0552
    ISSN (online) 1468-1331
    ISSN 1351-5101 ; 1471-0552
    DOI 10.1111/ene.15310
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top